After studying 456 different types of tumors, scientists at the University of Glasgow have categorized pancreatic cancer into four distinct subgroups: squamous, pancreatic progenitor, immunogenic, and ADEX.

According to Leanne Reynolds, head of research for the Pancreatic Cancer UK charity, only about 4% of pancreatic cancer patients live 5 years beyond their diagnosis. Being able to differentiate between the sub-types of pancreatic cancer should allow physicians to offer more specific treatment options along with a more accurate prognosis, hopefully leading to an improved survival rate for patients suffering from the disease.

Click here to read the publication in the journal Nature. Click here to read the news release on the University's website.